Navigation Links
Echo Therapeutics Receives Funding and Commitment of Approximately $5.5 Million
Date:1/6/2011

FRANKLIN, Mass., Jan. 6, 2011 /PRNewswire/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude™ SkinPrep System for transdermal drug delivery, today announced that it has raised approximately $2.5 million through a series of private placements of the Company's stock and warrants, and it has received a binding commitment for an additional $3 million.  The funding was led by the Company's largest shareholder, Platinum Montaur Life Sciences, LLC ("Montaur").  Current investors and other select institutional and accredited investors also participated in the financings.  Echo expects to use the net proceeds for product development, clinical studies, working capital and general corporate purposes.  

Echo conducted a private placement of common stock and warrants with aggregate proceeds of approximately $2.5 million through a series of closings held from November 2010 through January 2011.  Investors purchased units, or partial units, at a price per unit of $25,000, consisting of (i) 25,000 shares of Echo common stock, (ii) Series 1 warrants to purchase 12,500 shares of Echo common stock with an exercise price of $1.50 per share, and (iii) Series 2 warrants to purchase 12,500 shares of Echo common stock with an exercise price of $2.50 per share.  

On January 5, 2011, Echo also received a $3 million funding commitment from Montaur. Montaur will advance $1 million of the committed funds to Echo pursuant to a bridge note, which is intended to convert into convertible preferred stock no later than February 1, 2011.  Montaur has agreed to invest an additional $2 million through the purchase of convertible preferred stock in monthly installments from February through May 2011.  
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
2. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco, CA
3. Amicus Therapeutics to Present at the 29th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2011
4. Halozyme Therapeutics to Present at J.P. Morgan Healthcare Conference on January 12
5. Karyopharm Therapeutics Inc. Appoints Michael Kauffman, MD, PhD, as Chief Executive Officer
6. Intarcia Therapeutics Executive Chairman Kurt Graves to Present at 29th Annual JP Morgan Healthcare Conference
7. Vicus Therapeutics Announces Initiation of Phase 2 Trial to Evaluate VT-122 in Patients with Liver Cancer Receiving Nexavar
8. King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY®
9. PTC Therapeutics Completes Enrollment of Phase 3 Trial of Ataluren in Patients with Cystic Fibrosis
10. Silence Therapeutics Provides Year-end Update
11. Angelica Therapeutics Receives a $244,479 Qualified Therapeutic Discovery Project Grant for Its Anti-Cancer Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... The American Association for Homecare (AAHomecare) is ... has joined the AAHomecare Corporate Partner Program. ... have been actively involved in AAHomecare for much of ... grown into a major global manufacturer of home medical ... to increase efforts on behalf of the HME sector ...
(Date:9/19/2014)... 2014 UBM Medica US announces that  ... to help oncologists and other clinicians gain a better ... of targeted therapies and immunotherapies, discusses some of the ... Every September, Blood Cancer Awareness Month ... about blood cancers—helping to increase survival rates and improve ...
(Date:9/19/2014)... -- Larry J. Merlo , President and CEO of ... the National Press Club in Washington, D.C. ... stop selling tobacco products and its leadership in driving the ... "Dramatic changes in our health care system pose enormous challenges ... said. "CVS Health has a truly unique combination of business ...
Breaking Medicine Technology:Drive Medical Design & Manufacturing Joins AAHomecare Corporate Partner Program 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 2CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 3
... Savient Pharmaceuticals, Inc. (NASDAQ: SVNT ) today reported ... 30, 2011, which reflect the Company,s continuing investment in the ... $202.7 million in cash and short-term investments, a decrease of ... 2011, the Company had a net loss of $27.4 million, ...
... The American College of Emergency Physicians, a national sponsor ... public about safe disposal of expired, unused and unwanted ... abuse or accidental overdose.  A recent study reports that ... deaths in 2008, more than half of the total ...
Cached Medicine Technology:Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 2Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 3Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 4Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 5Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 6Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 7Emergency Physicians Tell the Public,''Get Rid of Your Stash'' of Unwanted Meds on November 12th 2
(Date:9/19/2014)... Top 10 Best SEO Hosting, ... HostGator.com, GoDaddy and Bluehost are among the best ... the most recommended suppliers for webmasters from the ... high quality Linux hosting (including VPS and cloud ... of many top hosting companies that started thinking ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 Singulair, developed ... physiologic actions of leukotriene D4 (LTD4). LTD4 belongs to ... a variety of cells, including mast cells and eosinophils, ... Several studies have determined that there are higher concentrations ... compared with non-asthmatic individuals. The production of CysLTs is ...
(Date:9/19/2014)... September 19, 2014 Follow ... assays used for detection and quantification of the ... sample. Driven by steady expansion in immunodiagnostics and ... global immunoassay systems market has evolved remarkably well ... such as diabetes, cardio-vascular ailments, infectious diseases, allergy ...
(Date:9/19/2014)... MD & Salt Lake City, UT (PRWEB) September 19, ... to launch the new Activz Greens Smoothie ... Products Expo East, September 18th-20th in Baltimore, MD. ... with 8 organic super foods combined in one convenient ... Natural Products Expo East, September 18th-20th in Baltimore, MD. ...
(Date:9/19/2014)... grow well in infertile land, and bear many beans ... is because most legumes have a symbiotic relationship with ... air and then supply the host plant with ammonia ... organs called nodules in their roots. However, if too ... the growth of the plants, because the energy cost ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com Announces Great Linux Web Hosting Suppliers In 2014 2Health News:Singulair Asthma Market to 2023 – Etiology, Pathophysiology, Diagnosis & Treatment Overview in New Report Available at LifeScienceIndustryResearch.com 2Health News:Singulair Asthma Market to 2023 – Etiology, Pathophysiology, Diagnosis & Treatment Overview in New Report Available at LifeScienceIndustryResearch.com 3Health News:Singulair Asthma Market to 2023 – Etiology, Pathophysiology, Diagnosis & Treatment Overview in New Report Available at LifeScienceIndustryResearch.com 4Health News:Growing Preference for Non-Invasive Diagnostics Spurs Growth in the Global Immunoassay Systems Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Growing Preference for Non-Invasive Diagnostics Spurs Growth in the Global Immunoassay Systems Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Growing Preference for Non-Invasive Diagnostics Spurs Growth in the Global Immunoassay Systems Market, According to New Report by Global Industry Analysts, Inc. 4Health News:New Activz Greens Smoothie with 8 Organic Superfoods & More Launched at Natural Products Expo East 2Health News:New Activz Greens Smoothie with 8 Organic Superfoods & More Launched at Natural Products Expo East 3Health News:Long-distance communication from leaves to roots 2
... Reporter , MONDAY, Aug. 23 (HealthDay News) -- While the ... report that the incidence of rectal cancer among people under ... young person,s chance of developing the disease remains tiny, but ... Dr. David L. Sherr, an assistant professor of radiation oncology ...
... HealthDay Reporter , MONDAY, Aug. 23 (HealthDay News) -- ... salmonella, the head of the U.S. Food and Drug Administration ... sub-recalls over the next couple of days, maybe even weeks, ... eggs that are contaminated," agency director Margaret Hamburg told NBC,s ...
... Gold Standard/Elsevier, a leading developer of drug ... launch of MEDcounselor Languages, a module that provides ... languages. The new MEDcounselor Languages will enable ... understand their drug therapy, take their medications safely, ...
... HealthDay Reporter , SUNDAY, Aug. 22 (HealthDay News) -- ... protein encoded by the BRCA2 gene. Dysfunction of this ... By separating the protein from the rest of the components ... and figure out exactly what it does in the body. ...
... while colon cancer rates have remained steady over the past ... cancer rates are increasing in this population across races and ... a peer-reviewed journal of the American Cancer Society, the study ... in young individuals who show potential signs of the disease. ...
... study of egg cells using time-lapse microscopy, researchers at ... and the Ludwig Institute for Cancer Research have discovered ... produces reproductive cells in sexually reproducing organisms. The ... cell chromosomes separate from each other may shed light ...
Cached Medicine News:Health News:Rectal Cancer Rates on the Rise in Younger Adults 2Health News:FDA Chief Says More Egg Recalls Possible 2Health News:FDA Chief Says More Egg Recalls Possible 3Health News:FDA Chief Says More Egg Recalls Possible 4Health News:Gold Standard/Elsevier promotes medication safety and compliance via New MEDcounselor languages 2Health News:Inner Workings of Gene Tied to Breast, Ovarian Cancer Revealed 2Health News:Inner Workings of Gene Tied to Breast, Ovarian Cancer Revealed 3Health News:Rectal cancer rates are rising in young individuals 2Health News:Study of cell division sheds light on special mechanism in egg cells 2
MONOJECT Red/Yellow Mottled Stopper...
... BD Vacutainer® SST™ Tubes ... a polymer gel for ... used for serum determinations ... provide an efficient means ...
BD Vacutainer® Specialty Tubes - Sedimentation Rate Determination (SRD)...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Medicine Products: